General Statement of Disclosure:
CONSULTING FEES/HONORARIA: AstraZeneca Pharmaceuticals(MODEST), Boston Scientific(MODEST), Merck & Co., Inc.(MODEST), American Regent(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Novartis Corporation(NONE), Daiichi Sankyo(MODEST), Roche(MODEST)